HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniela Wesch Selected Research
Daniela Wesch Research Topics
Disease
42
Neoplasms (Cancer)
01/2022 - 01/2003
11
Adenocarcinoma
01/2020 - 12/2004
4
Infections
01/2020 - 01/2003
3
Breast Neoplasms (Breast Cancer)
01/2022 - 01/2018
3
Carcinogenesis
12/2019 - 03/2015
3
Pancreatic Neoplasms (Pancreatic Cancer)
03/2015 - 03/2014
2
Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 03/2018
2
Inflammation (Inflammations)
12/2019 - 01/2003
2
Leukemia
01/2019 - 01/2007
2
Lymphoma (Lymphomas)
01/2019 - 01/2007
2
Hypersensitivity (Allergy)
11/2016 - 06/2011
2
Respiratory Insufficiency (Respiratory Failure)
06/2014 - 11/2012
2
Lung Injury
06/2014 - 08/2012
2
Acute Lung Injury
11/2012 - 08/2012
1
Bites and Stings (Sting)
01/2022
1
Obesity
05/2021
1
Type 2 Diabetes Mellitus (MODY)
05/2021
1
Esophageal Neoplasms (Esophageal Cancer)
01/2018
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017
1
Glioblastoma (Glioblastoma Multiforme)
01/2017
1
Glioma (Gliomas)
04/2016
1
Neoplasm Metastasis (Metastasis)
03/2015
1
Pneumonia (Pneumonitis)
06/2014
1
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2014
Drug/Important Bio-Agent (IBA)
13
Ligands
IBA
01/2022 - 01/2007
7
Antigens
IBA
01/2022 - 01/2014
7
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2018 - 01/2007
5
Cytokines
IBA
01/2022 - 07/2009
5
Bispecific Antibodies
IBA
01/2020 - 01/2014
4
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 11/2016
3
Carrier Proteins (Binding Protein)
IBA
01/2022 - 04/2016
3
Diphosphates (Pyrophosphates)
IBA
01/2021 - 03/2013
3
Neoplasm Antigens (Tumor Antigens)
IBA
01/2020 - 03/2014
3
Disintegrins
IBA
03/2018 - 10/2013
3
Metalloproteases (Metalloproteinases)
IBA
03/2018 - 10/2013
3
Surface-Active Agents (Surfactants)
IBA
06/2014 - 08/2012
3
Lipopolysaccharides
IBA
06/2014 - 01/2010
2
human ERBB2 protein
IBA
01/2022 - 01/2018
2
Immunoglobulin G (IgG)
IBA
01/2022 - 01/2021
2
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2020 - 11/2009
2
Platinum
IBA
01/2020 - 03/2018
2
Granzymes (Granzyme)
IBA
01/2019 - 11/2009
2
Monoclonal Antibodies
IBA
01/2018 - 07/2009
2
Trastuzumab (Herceptin)
FDA Link
01/2018 - 11/2016
2
Surface Antigens (Surface Antigen)
IBA
01/2018 - 03/2013
2
NK Cell Lectin-Like Receptor Subfamily K
IBA
01/2017 - 04/2016
2
diphosphoric acid (pyrophosphoric acid)
IBA
11/2016 - 01/2010
2
mica
IBA
04/2016 - 10/2013
2
Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)
IBA
07/2014 - 01/2014
2
Enzymes
IBA
10/2013 - 08/2012
2
Acids
IBA
11/2012 - 08/2012
2
Ceramides
IBA
11/2012 - 08/2012
2
Sphingomyelin Phosphodiesterase (Sphingomyelinase)
IBA
11/2012 - 08/2012
2
Proteins (Proteins, Gene)
FDA Link
01/2007 - 04/2006
1
Antibodies
IBA
01/2022
1
Interferons
IBA
01/2022
1
Biological Products
IBA
01/2022
1
Zoledronic Acid (Zometa)
FDA Link
01/2022
1
Blood Glucose (Blood Sugar)
IBA
05/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
Cetuximab (Erbitux)
FDA Link
01/2021
1
Fc Receptors (Fc Receptor)
IBA
01/2021
1
Natural Killer Cell Receptors
IBA
01/2021
1
Galectins (Galectin)
IBA
11/2020
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
11/2020
1
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
IBA
11/2020
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2020
1
Kynurenine
IBA
01/2020
1
resiquimod
IBA
01/2020
1
Galectin 3 (LGALS3)
IBA
01/2020
1
Chitosan
IBA
01/2020
1
Succinate Dehydrogenase (Fumarate Reductase)
IBA
12/2019
1
Perforin
IBA
01/2019
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
01/2019
1
TNF-Related Apoptosis-Inducing Ligand
IBA
01/2019
1
Cisplatin (Platino)
FDA Link
Generic
03/2018
1
Amphiregulin
IBA
03/2018
1
Immunoglobulin Fab Fragments
IBA
01/2018
1
pertuzumab
IBA
01/2018
1
Tyrosine Kinase Inhibitors
IBA
11/2017
1
Steroids
IBA
01/2017
1
Interleukin-17 (Interleukin 17)
IBA
01/2017
1
Interleukin-9 (Interleukin 9)
IBA
11/2016
1
Temozolomide (Temodar)
FDA Link
Generic
04/2016
1
Diphosphonates (Bisphosphonates)
IBA
07/2015
1
Nitrogen
IBA
07/2015
1
Ligases (Synthetase)
IBA
03/2015
1
Prostaglandins
IBA
03/2015
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
03/2015
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
03/2015
1
Secretory Phospholipases A2
IBA
06/2014
1
Phosphatidylglycerols
IBA
06/2014
1
1,2- dioleoyl- sn- glycero- 3- phosphoglycerol (DOPG)
IBA
06/2014
Therapy/Procedure
20
Immunotherapy
01/2022 - 12/2004
7
Therapeutics
01/2022 - 12/2004
2
Drug Therapy (Chemotherapy)
03/2018 - 01/2014
2
Artificial Respiration (Mechanical Ventilation)
06/2014 - 11/2012
1
Resistance Training
03/2018
1
Adjuvant Chemotherapy
03/2018
1
Chemoradiotherapy
01/2017